GILD
Price:
$78.72
Market Cap:
$98.01B
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an ora...[Read more]
Industry
Drug Manufacturers - General
IPO Date
1992-01-22
Stock Exchange
NASDAQ
Ticker
GILD
According to Gilead Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 118.58B. This represents a change of 5.11% compared to the average of 112.81B of the last 4 quarters.
The mean historical Enterprise Value of Gilead Sciences, Inc. over the last ten years is 114.71B. The current 118.58B Enterprise Value has changed 10.24% with respect to the historical average. Over the past ten years (40 quarters), GILD's Enterprise Value was at its highest in in the June 2015 quarter at 164.93B. The Enterprise Value was at its lowest in in the December 2018 quarter at 90.07B.
Average
114.71B
Median
116.80B
Minimum
90.57B
Maximum
135.29B
Discovering the peaks and valleys of Gilead Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 18.36%
Maximum Annual Enterprise Value = 135.29B
Minimum Annual Increase = -24.26%
Minimum Annual Enterprise Value = 90.57B
Year | Enterprise Value | Change |
---|---|---|
2023 | 120.00B | -5.92% |
2022 | 127.56B | 13.33% |
2021 | 112.56B | 14.11% |
2020 | 98.64B | 3.30% |
2019 | 95.49B | 5.43% |
2018 | 90.57B | -24.26% |
2017 | 119.59B | 4.90% |
2016 | 114.00B | -15.74% |
2015 | 135.29B | 1.38% |
2014 | 133.45B | 18.36% |
The current Enterprise Value of Gilead Sciences, Inc. (GILD) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
120.04B
5-year avg
110.85B
10-year avg
114.71B
Gilead Sciences, Inc.’s Enterprise Value is less than Amgen Inc. (225.59B), less than Merck & Co., Inc. (325.14B), less than AbbVie Inc. (399.11B), less than Johnson & Johnson (412.32B), less than Bristol-Myers Squibb Company (146.44B), less than Pfizer Inc. (230.24B), less than Eli Lilly and Company (883.63B), less than AstraZeneca PLC (284.12B),
Company | Enterprise Value | Market cap |
---|---|---|
225.59B | $172.25B | |
325.14B | $298.70B | |
399.11B | $341.61B | |
412.32B | $395.70B | |
146.44B | $98.73B | |
230.24B | $161.84B | |
883.63B | $857.96B | |
284.12B | $257.50B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gilead Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gilead Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Gilead Sciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Gilead Sciences, Inc. (GILD)?
What is the 3-year average Enterprise Value for Gilead Sciences, Inc. (GILD)?
What is the 5-year average Enterprise Value for Gilead Sciences, Inc. (GILD)?
How does the current Enterprise Value for Gilead Sciences, Inc. (GILD) compare to its historical average?